Few investors cheered the election of Donald Trump as much as those who held large positions in pharmaceutical stocks, and his victory has prompted a wave of relief across the sector.
Whereas bank bashing was popular among other Democrats, Hillary Clinton spent the past year targeting drugmakers in an attempt to tap into public anger at the soaring price of medicines.
Mr Trump said relatively little about drug prices during the campaign and instead focused on his pledge to repeal the Affordable Care Act, commonly known as Obamacare.
Whereas bank bashing was popular among other Democrats, Hillary Clinton spent the past year targeting drugmakers in an attempt to tap into public anger at the soaring price of medicines.
Mr Trump said relatively little about drug prices during the campaign and instead focused on his pledge to repeal the Affordable Care Act, commonly known as Obamacare.
